Icu Medical (ICUI) Net Income towards Common Stockholders (2009 - 2026)

Icu Medical (ICUI) has reported Net Income towards Common Stockholders for 18 consecutive years, with $16.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 53.8% year-over-year to $16.1 million; the trailing twelve-month figure through Jun 2026 stood at $33.4 million (up 195.7% YoY), and the FY2025 full-year result was $1.9 million, up 101.63% from the prior year.
• Net Income towards Common Stockholders retreated to $16.1 million in Q2 2026 per ICUI's latest filing, from $32.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $34.8 million in Q2 2025 and bottomed at -$38.1 million in Q1 2022.
• Historically, Net Income towards Common Stockholders has averaged -$8.4 million across 5 years, with a median of -$13.0 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders tumbled 555.69% in 2024, then soared 352.12% in 2026.
• Over 5 years, Net Income towards Common Stockholders stood at -$15.5 million in 2022, then slipped by 10.37% to -$17.1 million in 2023, then slumped by 38.96% to -$23.8 million in 2024, then soared by 44.4% to -$13.2 million in 2025, then soared by 221.32% to $16.1 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $16.1 million, $32.4 million, and -$13.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.